Comparing the effects of biguanides and dipeptidyl peptidase-4 inhibitors on cardio-cerebrovascular outcomes, nephropathy, retinopathy, neuropathy, and treatment costs in diabetic patients
In patients with T2DM who initiate pharmacotherapy, there were no differences in the long-term incidences of cardio-cerebrovascular events or complications associated with biguanide or DPP-4 use, but the former was less costly.
Authors
- Hiromichi Yui
- Takayoshi Nagahama
- Hiromitsu Ohno
- Taku Matsunaga
- Chikara Ueki
- Nagato Kuriyama (ORCID: https://orcid.org/0000-0002-6859-535X)
- Toru Tonoike
- Daito Funaki (ORCID: https://orcid.org/0009-0009-2566-9839)
- Akinori Miyakoshi (ORCID: https://orcid.org/0000-0001-7547-2828)
- Akira Sugawara (ORCID: https://orcid.org/0000-0003-4511-8101)
- Hiraku Kumamaru (ORCID: https://orcid.org/0000-0002-9759-6191)
- Eiji Nakatani (ORCID: https://orcid.org/0000-0002-4876-446X)
- Yoshihiro Tanaka (ORCID: https://orcid.org/0000-0002-7468-8886)
- Ataru Igarashi (ORCID: https://orcid.org/0000-0001-6307-6916)
- Tatsunori Satoh (ORCID: https://orcid.org/0000-0002-1756-3147)
Institutions
- Shizuoka General Hospital (JP)
- The University of Tokyo (JP)
- Yokohama City University (JP)
Publication Details
- Journal
- PLoS ONE
- Published
- 2024-08-09
- DOI
- https://doi.org/10.1371/journal.pone.0308734
- Citations
- 4
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 1.43